Skip to content

Transcutaneous electrical acupoint stimulation for hypertension complicated with anxiety or sleep disorder: a pilot randomized controlled trial

Transcutaneous electrical acupoint stimulation for hypertension complicated with anxiety or sleep disorder: a pilot randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069954
Enrollment
Unknown
Registered
2023-03-30
Start date
2023-05-23
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension with anxiety and/or sleep disorder

Interventions

Low frequency acupoint stimulation group:TEAS-2Hz+routine treatment
High frequency acupoint stimulation group:TEAS-10Hz+routine treatment

Sponsors

Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Meets diagnostic criteria for hypertension. 2.Patients aged 18 to 65 years old, male or female 3.Pittsburgh Sleep Quality Index (PSQI)>5 and/or Generalized Anxiety Disorder 7-item scale(GAD-7)>4. 4.No language or intellectual impairment, can smoothly answer and fill out questionnaires. 5.Seek the consent of the subject patient or their guardian and be willing to participate. 6.The office systolic BP should be 140-159 mmHg and/or diastolic BP should be 90-99 mmHg without the use of anti-hypertensive medications at three visits on different days. If having hypertensive history and currently using anti-hypertensive medications, office systolic BP should be 120-159 mmHg and/or diastolic BP should be 80-99 mmHg.

Exclusion criteria

Exclusion criteria: 1.Contraindications to the use of electric acupuncture apparatus : patients with cardiac pacemakers or other implanted medical devices; suffering from acute diseases, infectious diseases, malignant tumors, other cardiovascular diseases, cerebrovascular diseases, liver and kidney dysfunction, or other malignant diseases; wounds, abrasions, new scars, or inflammation on the skin at the acupoints. 2.Hypertension caused by renal parenchymal hypertension, renal artery stenosis, and other vascular diseases, primary aldosteronism, and other endocrine hypertension, as well as secondary hypertension caused by other causes. 3.Using drugs that affect blood pressure, such as glucocorticoids, central nervous system inhibitors. 4.Out of control diabetes mellitus. 5.Have received hormone treatment or acupuncture and moxibustion treatment in the past month. 6.Suspected or confirmed history of alcohol and drug abuse. 7.Women in preparation for pregnancy,women of childbearing age without contraception, pregnant women, and lactating women 8.Enrolled in other clinical trials.

Design outcomes

Primary

MeasureTime frame
SBP;

Secondary

MeasureTime frame
Anxiety state of Patients;The sleep quality of patients;Heart rate;Rescue medication use and other treatments;Adverse events;DBP;

Countries

China

Contacts

Public ContactWang Liqiong

Beijing University of Chinese Medicine

wangliqiongwork@163.com+86 185 1175 5226

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026